Member Info for Filter29

Mulder feeling sorry for Lanstead now? Lol, what a plum

Yes unfortunately as far as any interest from major pharma goes we're in the dark until made public.

He said the data is cheap to generate, thank god for that!

Dan said in the last proactive interview, after the next set of data for 002, due near term, they will be able to initiate discussions with major pharma.

It's been painful but going in the right direction

I believe that over the next 3 months significant strides will be made and the share price will recover to a respectable level meaning more cashflow, that's my hope anyway going by the investor presentation and interviews.

Read through the last investor presentation again, this quarter should see a lot of data produced and more progress. Lanstead is what it is, I'm sure DG is desperate to raise the SP to make it more profitable, confident we're in for a very strong year

Just had a top up of 140000 @ 0.299p, bring on some value making news it's about time

The year of NFX finally living upto the potential I hope!

Unfortunately Lanstead is a bit of a millstone, just can't hold any rise in SP which is a constant frustration. How I wish they did a normal placing and for more cash, get the pain out the way then there would be no doubts over cash runway

Or just really good news?

You would think so, £2m mcap!

"with no hope of recovering", how do you know that?

It was always going to drift before the Christmas break, see where we are at the end of Q1

Talks of delisting are going too far imo, the bod do need to pull their fingers out the next 3 months though, it 'could' be a news rich Q1 with delayed news and 004 updates

I would express my views to IR but it's always the same answer.

As usual it's wait and see and fingers crossed it's good news for shareholders for a change.

Filter Mulder, just see a green box it's great

Anyway, as much as I hate what's happened here over the last 3 years it's all about moving forward now at a ridiculous £2.5 mcap. We need any kind of interest from larger pharma's, we have no idea how appealing we are to them really, after more data we'll hopefully see interested parties come forward

Seems not receiving the money from the china deal started the whole downfall, it could've been so much different

The NXP004 update is well overdue, we know about the NXP002 delay

Exactly as expected, nothing new, awaiting some kind of licensing discussions or JV.

Yeah it is what it is with Lanstead, I'm bored of moaning about it, only significant news will shift us back to around 2p level which of course is still disappointing for long term shareholders.

One things for sure, we should not be in this position this time next year. I've said that every year lol but 2.5m mcap!! No chance

Ah yes I totally forgot, trying to block out bad news I guess! Half year report will just be a half year report then, nothing interesting

True chab, I'm looking at mcap now, around £2.5m is mad when you look at the potential however the board need to get their act together.

Where are the H2 updates? Only had 1